Top 18 Landos Biopharma investors
The most complete profiles first. Showing 18 of 18.
Joshua KennedyVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Verified email available
Louis BernemanVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Manny StockmanVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Robert AdelsonVerified
Venture Capital, University Program, Investor · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more
Verified email available
Stephanie A. SirotaVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsEnterprise SoftwareInvestment ManagementPortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Verified email available
Chris GarabedianVerified
Venture Capital, Angel/Individual, Investment Partner · United States
SeedPre-SeedHealth CareAutoimmune DiseasesBiotechnologyClinical TrialsPortfolio: Tellus Therapeutics, Nephraegis Therapeutics, CereVasc, Landos Biopharma and 5 more
Verified email available
Anurag AgarwalVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Matt CohenVerified
Venture Capital, University Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Paul ManningVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation ServicesPortfolio: LEXEO Therapeutics, Nanoview Biosciences, PatientsLikeMe, Candel and 6 more
Verified email available
Marc Singer
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more
Contact details available
Naveen Yalamanchi
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Piratip Pratumsuwan
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more
Contact details available
Roderick Wong
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more
Contact details available
Sabera Loughran
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Tony Nguyen
Hedge Fund, Venture Capital, Investor · United States
Series BAdvertisingHealth CareGeneticsInvestment ManagementPortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
William Harrington
Venture Capital, University Program, Investor · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more
Contact details available
Jayson Rieger
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation ServicesPortfolio: LEXEO Therapeutics, Nanoview Biosciences, PatientsLikeMe, Candel and 6 more
Contact details available
Kirsten Leute
Venture Capital, University Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Landos Biopharma investors are on Angel Roster?
Angel Roster lists 18 Landos Biopharma investors. 9 of them (50%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (18), University Program Investors (8) and Hedge Funds (7). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Landos Biopharma investors invest in?
Among those that list a stage, the most common are Series B (7), Series A (5) and Pre-Seed (1).
Where are Landos Biopharma investors based?
Most are based in the United States (18).
Which companies have Landos Biopharma investors backed?
The most-backed portfolio companies among them are Atsena Therapeutics (10), IonQ (8), ESCAPE Bio (8), Homology Medicines (8) and Fortis Therapeutics (8).
How do I contact Landos Biopharma investors?
Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.